An elevated level of soluble suppression of tumorigenicity 2, but not galectin-3, is associated with the presence of coronary artery disease in hypertensive patients

• Published in: Hypertension research Vol. 48; no. 2; pp. 650 - 661
• Main Authors: Miura-Takahashi, Erika, Tsudome, Riku, Suematsu, Yasunori, Tachibana, Tetsuro, Kato, Yuta, Kuwano, Takashi, Sugihara, Makoto, Tashiro, Kokei, Shiga, Yuhei, Kamimura, Hidetoshi, Miura, Shin-ichiro
• Format: Journal Article
• Language: English
• Published: Singapore Springer Nature Singapore 01.02.2025; Nature Publishing Group
• Subjects: Aged; Blood Proteins; Cardiovascular disease; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease - blood; Coronary Artery Disease - complications; Coronary Artery Disease - diagnostic imaging; Coronary vessels; Female; Galectin 3 - blood; Galectins; Geriatrics/Gerontology; Health Promotion and Disease Prevention; Humans; Hypertension - blood; Hypertension - complications; Interleukin-1 Receptor-Like 1 Protein - blood; Internal Medicine; Male; Medicine; Medicine & Public Health; Middle Aged; Obstetrics/Perinatology/Midwifery; Public Health; Vein & artery diseases; Coronary artery computed tomography angiography; Galectin-3; Soluble suppression of tumorigenicity 2; Coronary artery disease

We investigated whether there were associations between coronary artery disease (CAD) and soluble suppression of tumorigenicity (sST2) and galectin-3 levels at the time of coronary artery computed tomography angiography (CCTA) for CAD screening. The subjects consisted of 429 patients who underwent C...